Moderna draws Monday attention after a 7.82% fall on Friday
Reports say Moderna's stock was back in the headlines on Monday, with an index change and a fund trade among the items.
Market reports say Moderna's shares were the subject of several stories on Monday. One report asks what is going on with the stock, another says an equal-weight S&P 500 fund sold Moderna shares on Thursday, and a third says the company joins the Nasdaq-100 index. The reports do not tie these items together, and one of them says the stock traded at EUR 192.95.
Moderna develops vaccines and medicines based on messenger RNA technology. Index inclusion and fund trades can change who holds the shares without any change to the business itself, so they are usually read separately from company results.
What our numbers show: Moderna last closed at $218.01 on 16 October 2026, a move of -7.82% on that trading day. Its X-Ray Score is 12 out of 100, and the fair value label from the site's models is Overvalued. The label is the output of those models, not advice.
Headlines change quickly. The company's own announcements and its SEC filings are the primary source for anything that affects the business.
MRNA on StocksXray
Educational only, not financial advice. Numbers beside the story are from our own data.